The stock of Solventum Corp (SOLV) has gone down by -4.54% for the week, with a -1.83% drop in the past month and a 2.36% rise in the past quarter. The volatility ratio for the week is 4.13%, and the volatility levels for the past 30 days are 3.48% for SOLV. The simple moving average for the past 20 days is -6.22% for SOLV’s stock, with a 9.33% simple moving average for the past 200 days.
Is It Worth Investing in Solventum Corp (NYSE: SOLV) Right Now?
The price-to-earnings ratio for Solventum Corp (NYSE: SOLV) is above average at 26.21x. The 36-month beta value for SOLV is also noteworthy at 0.44. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 9 rating it as “hold,” and 0 rating it as “sell.”
The public float for SOLV is 138.43M, and at present, short sellers hold a 3.10% of that float. The average trading volume of SOLV on March 14, 2025 was 994.02K shares.
SOLV) stock’s latest price update
Solventum Corp (NYSE: SOLV) has experienced a decline in its stock price by -2.31 compared to its previous closing price of 74.01. However, the company has seen a fall of -4.54% in its stock price over the last five trading days. prnewswire.com reported 2025-03-12 that ST. PAUL, Minn., March 12, 2025 /PRNewswire/ — Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an electronic test card and auto-reader for sterilization testing that eliminates the need for visual interpretation of results and manual documentation.
Analysts’ Opinion of SOLV
Many brokerage firms have already submitted their reports for SOLV stocks, with Mizuho repeating the rating for SOLV by listing it as a “Neutral.” The predicted price for SOLV in the upcoming period, according to Mizuho is $70 based on the research report published on December 04, 2024 of the previous year 2024.
Stifel, on the other hand, stated in their research note that they expect to see SOLV reach a price target of $82. The rating they have provided for SOLV stocks is “Buy” according to the report published on October 08th, 2024.
Piper Sandler gave a rating of “Neutral” to SOLV, setting the target price at $71 in the report published on October 07th of the previous year.
SOLV Trading at -2.32% from the 50-Day Moving Average
After a stumble in the market that brought SOLV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -24.73% of loss for the given period.
Volatility was left at 3.48%, however, over the last 30 days, the volatility rate increased by 4.13%, as shares sank -1.87% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.33% upper at present.
During the last 5 trading sessions, SOLV fell by -4.54%, which changed the moving average for the period of 200-days by +20.64% in comparison to the 20-day moving average, which settled at $77.10. In addition, Solventum Corp saw 9.45% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for SOLV
Current profitability levels for the company are sitting at:
- 0.13 for the present operating margin
- 0.56 for the gross margin
The net margin for Solventum Corp stands at 0.06. The total capital return value is set at 0.09.
Based on Solventum Corp (SOLV), the company’s capital structure generated 0.73 points at debt to capital in total, while cash flow to debt ratio is standing at 0.15. The debt to equity ratio resting at 2.71. The interest coverage ratio of the stock is 2.83.
Currently, EBITDA for the company is 1.53 billion with net debt to EBITDA at 4.6. When we switch over and look at the enterprise to sales, we see a ratio of 2.39. The receivables turnover for the company is 7.91for trailing twelve months and the total asset turnover is 0.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.20.
Conclusion
In summary, Solventum Corp (SOLV) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
